• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年人群中的新冠后真菌感染

Post-COVID-19 Fungal Infection in the Aged Population.

作者信息

Chavda Vivek P, Mishra Toshika, Kamaraj Sathvika, Punetha Swati, Sengupta Oishani, Joshi Yash, Vuppu Suneetha, Vaghela Dixa, Vora Lalitkumar

机构信息

Department of Pharmaceutics and Pharmaceutical Technology, L.M. College of Pharmacy, Ahmedabad 380009, Gujarat, India.

Science, Innovation, and Society Research Lab. 115, Department of Biotechnology, Hexagon (SMV), Vellore Institute of Technology, Vellore 632014, Tamil Nadu, India.

出版信息

Vaccines (Basel). 2023 Feb 27;11(3):555. doi: 10.3390/vaccines11030555.

DOI:10.3390/vaccines11030555
PMID:36992139
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10056493/
Abstract

Coronavirus disease 2019 (COVID-19) infection is currently a great cause of concern for the healthcare sector around the globe. SARS-CoV-2 is an RNA virus that causes a serious infection that is associated with numerous adverse effects and multiple complications associated with different organs and systems during its pathogenic cycle in humans. Individuals affected by COVID-19, especially elderly populations and immunocompromised people, are greatly vulnerable to opportunistic fungal pathogens. Aspergillosis, invasive candidiasis, and mucormycosis are widespread fungal coinfections in COVID-19 patients. Other fungal infections that are rare but are exhibiting increased incidence in the current scenario include infections caused by , sp., sp., etc. By producing virulent spores, these pathogens increase the severity of the disease and increase the morbidity and fatality rates in COVID-19 patients globally. These infections generally occur in patients recovering from COVID-19 infection, resulting in rehospitalization. Older and immunocompromised individuals are at higher risk of developing opportunistic fungal infections. This review focuses on understanding the opportunistic fungal infections prevalent in COVID-19 patients, especially elderly people. We have also highlighted the important preventive methods, diagnostic approaches, and prophylactic measures for fungal infections.

摘要

2019冠状病毒病(COVID-19)感染目前是全球医疗保健部门极为关注的问题。严重急性呼吸综合征冠状病毒2(SARS-CoV-2)是一种RNA病毒,可引起严重感染,在其人类致病周期中会导致多种不良反应以及与不同器官和系统相关的多种并发症。受COVID-19影响的个体,尤其是老年人群体和免疫功能低下的人群,极易感染机会性真菌病原体。曲霉病、侵袭性念珠菌病和毛霉病是COVID-19患者中广泛存在的真菌合并感染。其他在当前情况下罕见但发病率正在上升的真菌感染包括由、属、属等引起的感染。通过产生有剧毒的孢子,这些病原体会增加疾病的严重程度,并提高全球COVID-19患者的发病率和死亡率。这些感染通常发生在从COVID-19感染中康复的患者身上,导致再次住院。老年人和免疫功能低下的个体发生机会性真菌感染的风险更高。本综述着重于了解COVID-19患者,尤其是老年人中普遍存在的机会性真菌感染。我们还强调了真菌感染的重要预防方法、诊断方法和预防措施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67b7/10056493/2337028cb09d/vaccines-11-00555-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67b7/10056493/2337028cb09d/vaccines-11-00555-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67b7/10056493/2337028cb09d/vaccines-11-00555-g001.jpg

相似文献

1
Post-COVID-19 Fungal Infection in the Aged Population.老年人群中的新冠后真菌感染
Vaccines (Basel). 2023 Feb 27;11(3):555. doi: 10.3390/vaccines11030555.
2
Fungal pathogens and COVID-19.真菌病原体与新型冠状病毒肺炎
Curr Opin Microbiol. 2023 Oct;75:102365. doi: 10.1016/j.mib.2023.102365. Epub 2023 Aug 23.
3
The role of SARS-CoV-2 immunosuppression and the therapy used to manage COVID-19 disease in the emergence of opportunistic fungal infections: A review.严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)免疫抑制及用于治疗2019冠状病毒病(COVID-19)的疗法在机会性真菌感染发生中的作用:综述
Curr Res Biotechnol. 2022;4:337-349. doi: 10.1016/j.crbiot.2022.08.001. Epub 2022 Aug 3.
4
Root Causes of Fungal Coinfections in COVID-19 Infected Patients.新冠病毒感染患者合并真菌感染的根本原因
Infect Dis Rep. 2021 Dec 4;13(4):1018-1035. doi: 10.3390/idr13040093.
5
High mortality co-infections of COVID-19 patients: mucormycosis and other fungal infections.新冠病毒肺炎患者的高死亡率合并感染:毛霉菌病和其他真菌感染。
Discoveries (Craiova). 2021 Mar 31;9(1):e126. doi: 10.15190/d.2021.5.
6
Predisposing factors of important invasive fungal coinfections in COVID-19 patients: a review article.COVID-19 患者中重要侵袭性真菌感染的诱发因素:一篇综述文章。
J Int Med Res. 2021 Sep;49(9):3000605211043413. doi: 10.1177/03000605211043413.
7
Invasive Fungal Infections in Immunocompromised Conditions: Emphasis on COVID-19.免疫功能低下人群中的侵袭性真菌感染:重点关注 COVID-19。
Curr Microbiol. 2024 Oct 9;81(11):400. doi: 10.1007/s00284-024-03916-1.
8
A systematic review on SARS-CoV-2-associated fungal coinfections.关于 SARS-CoV-2 相关真菌感染的系统评价。
J Med Virol. 2022 Jan;94(1):99-109. doi: 10.1002/jmv.27358. Epub 2021 Oct 5.
9
Fungal co-infection in COVID-19 patients: Should we be concerned?新冠病毒感染患者中的真菌合并感染:我们应予以关注吗?
Rev Iberoam Micol. 2020 Apr-Jun;37(2):41-46. doi: 10.1016/j.riam.2020.07.001. Epub 2020 Sep 14.
10
Overview of COVID-19-Associated Invasive Fungal Infection.新型冠状病毒肺炎相关侵袭性真菌感染概述
Curr Fungal Infect Rep. 2022;16(3):87-97. doi: 10.1007/s12281-022-00434-0. Epub 2022 Jul 11.

引用本文的文献

1
Fungal Biofilm: An Overview of the Latest Nano-Strategies.真菌生物膜:最新纳米策略概述
Antibiotics (Basel). 2025 Jul 17;14(7):718. doi: 10.3390/antibiotics14070718.
2
Role of rs5743708 and dectin-1 rs16910526 polymorphisms in susceptibility to fungal infections in COVID-19 patients.rs5743708和dectin-1 rs16910526基因多态性在COVID-19患者真菌感染易感性中的作用
Cent Eur J Immunol. 2025;50(1):77-86. doi: 10.5114/ceji.2025.149165. Epub 2025 May 5.
3
Fungal Pulmonary Coinfections in COVID-19: Microbiological Assessment, Inflammatory Profiles, and Clinical Outcomes.

本文引用的文献

1
Co-infection associated with SARS-CoV-2 and their management.与严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)相关的合并感染及其管理。
Future Sci OA. 2023 Feb 3;8(9):FSO819. doi: 10.2144/fsoa-2022-0011. eCollection 2022 Oct.
2
Mucormycosis an added burden to Covid-19 Patients: An in-depth systematic review.毛霉菌病给新冠病毒患者带来额外负担:一项深入的系统评价。
J Infect Public Health. 2022 Nov;15(11):1299-1314. doi: 10.1016/j.jiph.2022.10.011. Epub 2022 Oct 14.
3
Current treatments against mucormycosis and future directions.当前针对毛霉病的治疗方法和未来方向。
COVID-19患者的真菌肺部合并感染:微生物学评估、炎症特征及临床结局
Biomedicines. 2025 Apr 3;13(4):864. doi: 10.3390/biomedicines13040864.
4
Health of Saudi Women in the Post-Pandemic Era: Incidence and Post COVID-19 and COVID-19-Vaccination.疫情后时代沙特女性的健康:新冠疫情感染率、康复情况及新冠疫苗接种情况
Int J Womens Health. 2024 Oct 13;16:1687-1697. doi: 10.2147/IJWH.S472953. eCollection 2024.
5
Invasive Fungal Infections in Immunocompromised Conditions: Emphasis on COVID-19.免疫功能低下人群中的侵袭性真菌感染:重点关注 COVID-19。
Curr Microbiol. 2024 Oct 9;81(11):400. doi: 10.1007/s00284-024-03916-1.
6
Identification and characterization of a novel antifungal compound tubeimoside I targeting cell wall.鉴定和表征一种新型抗真菌化合物—— tubeimoside I,作用靶点为细胞壁。
Microbiol Spectr. 2024 Jun 4;12(6):e0404723. doi: 10.1128/spectrum.04047-23. Epub 2024 Apr 23.
7
Insights on Covid-19 with superimposed pulmonary histoplasmosis: The possible nexus.新冠合并肺组织胞浆菌病的研究进展:可能存在的关联。
Immun Inflamm Dis. 2023 Sep;11(9):e989. doi: 10.1002/iid3.989.
8
Increased Fungal Infection Mortality Induced by Concurrent Viral Cellular Manipulations.病毒对细胞的操纵会增加真菌感染死亡率。
Lung. 2023 Oct;201(5):467-476. doi: 10.1007/s00408-023-00642-6. Epub 2023 Sep 5.
9
Synergy and Mechanism of Leflunomide Plus Fluconazole Against Resistant : An in vitro Study.来氟米特联合氟康唑抗耐药的协同作用及机制:一项体外研究
Infect Drug Resist. 2023 Jun 27;16:4147-4158. doi: 10.2147/IDR.S415229. eCollection 2023.
PLoS Pathog. 2022 Oct 13;18(10):e1010858. doi: 10.1371/journal.ppat.1010858. eCollection 2022 Oct.
4
Invasive Mucormycosis and Aspergillosis Coinfection Associated with Post-COVID-19 Pneumonia in a Tertiary Care Hospital.在一家三级保健医院中,COVID-19 后肺炎并发侵袭性毛霉病和曲霉病感染。
Med Mycol J. 2022;63(3):59-64. doi: 10.3314/mmj.21-00019.
5
Pulmonary cryptococcosis after recovery from COVID-19 in an immunocompetent patient: A rare case report.免疫功能正常的 COVID-19 康复患者继发肺部隐球菌病:一例罕见病例报告。
Medicine (Baltimore). 2022 Aug 12;101(32):e30143. doi: 10.1097/MD.0000000000030143.
6
A Care Step Pathway for the Diagnosis and Treatment of COVID-19-Associated Invasive Fungal Infections in the Intensive Care Unit.重症监护病房中新型冠状病毒肺炎相关侵袭性真菌感染的诊断与治疗护理路径
Crit Care Nurse. 2022 Dec 1;42(6):36-46. doi: 10.4037/ccn2022237.
7
COVID-19-associated fungal infections.COVID-19 相关真菌感染。
Nat Microbiol. 2022 Aug;7(8):1127-1140. doi: 10.1038/s41564-022-01172-2. Epub 2022 Aug 2.
8
Fungal Infection in Co-infected Patients With COVID-19: An Overview of Case Reports/Case Series and Systematic Review.新冠病毒合并感染患者的真菌感染:病例报告/病例系列概述与系统评价
Front Microbiol. 2022 Jul 6;13:888452. doi: 10.3389/fmicb.2022.888452. eCollection 2022.
9
Overview of COVID-19-Associated Invasive Fungal Infection.新型冠状病毒肺炎相关侵袭性真菌感染概述
Curr Fungal Infect Rep. 2022;16(3):87-97. doi: 10.1007/s12281-022-00434-0. Epub 2022 Jul 11.
10
Current Treatment Options for COVID-19 Associated Mucormycosis: Present Status and Future Perspectives.2019冠状病毒病相关毛霉病的当前治疗选择:现状与未来展望
J Clin Med. 2022 Jun 23;11(13):3620. doi: 10.3390/jcm11133620.